Leukemia and Lymphoma, 1042-8194

Journal

  1. 2020
  2. 2019
  3. 2017
  4. 2016
  5. 2015
  6. 2014
  7. 2013
  8. Abouyahya, I., Alhan, C., Westers, T. M., te Boekhorst, P. A., Kappers-Klunne, M. C., Coenen, J. L., ... van de Loosdrecht, A. A. (2013). Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: results from the Dutch named patient program. Leukemia and Lymphoma, 54(4), 874-877. https://doi.org/10.3109/10428194.2012.728702
  9. 2012
  10. Kuper-Hommel, M. J. J., Janssen-Heijnen, M. L. G., Vreugdenhil, G., Krol, A. D. G., Kluin-Nelemans, H. C., Coebergh, J-W. W., & van Krieken, J. H. J. M. (2012). Clinical and pathological features of testicular diffuse large B-cell lymphoma: a heterogeneous disease. Leukemia and Lymphoma, 53(2), 242-246. https://doi.org/10.3109/10428194.2011.607528
  11. 2011
  12. 2010
  13. Gascoyne, R. D., Rosenwald, A., Poppema, S., & Lenz, G. (2010). Prognostic biomarkers in malignant lymphomas. Leukemia & Lymphoma, 51(Suppl. 1), 11-19. https://doi.org/10.3109/10428194.2010.500046
  14. 2009
  15. 2007
  16. 2004
  17. Van Rossum, MM., Verhaegen, NTM., Jonkman, MF., Mackenzie, MA., Koster, A., Van der Valk, PGM., & Span, LFR. (2004). Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: Case report with review of novel treatment modalities. Leukemia and Lymphoma, 45(11), 2327-2332. https://doi.org/10.1080/10428190410001733781
  18. 2003
  19. 2002
  20. 2001
  21. 1999
  22. 1998
  23. 1997
  24. 1996

ID: 1556484